MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, IGC had -$693K decrease in cash & cash equivalents over the period. -$1,224K in free cash flow.

Cash Flow Overview

Change in Cash
-$693K
Free Cash flow
-$1,224K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Common stock-based compensation ...
    • Net proceeds from the loan
    • Accounts payable
    • Others
Negative Cash Flow Breakdown
    • Net proceeds from the issuance o...
    • Net loss
    • Acquisition and development of i...
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net loss
-2,402 -726 -1,821 -1,599
Depreciation and amortization
58 64 119 141
Provision for bad debt
-0 --
Impairment of assets
0 0 --
Common stock-based compensation and expenses, net
1,009 926 730 452
Other items
20 -2,155 -1,055 -24
Accounts receivable, net
24 -29 -46 53
Inventory
0 -19 -6 -11
Deposits and advances
37 25 -37 -183
Claims and advances
-10 -3 -8 0
Accounts payable
241 384 -303 51
Accrued and other liabilities
-98 258 93 -599
Operating lease asset
-2 -2 -53 -32
Operating lease liability
-2 -2 -3 -2
Net cash used in operating activities
-1,223 -1,223 -2,090 -1,407
Purchase of property, plant, and equipment
1 12 29 8
Sale of property, plant, and equipment
0 2 -23 702
Investment in short-term investment
--25 -
Investment in short-term investments
-50 --
Acquisition and development of intangible assets
169 193 297 114
Net cash used in investing activities
-170 -228 -374 580
Repayment of a long-term loan
----1
Net proceeds from the issuance of common stock
-3,876 -3,111 852
Proceeds from common stock subscribed
-5,228 --
Repayment of long-term loan
-1 2 -
Net proceeds from the loan
623 ---
Net cash provided by financing activities
710 1,264 3,110 851
Effects of exchange rate changes on cash and cash equivalents
-10 -18 5 25
Net decrease in cash and cash equivalents
-693 -205 651 49
Cash and cash equivalents at the beginning of the period
900 1,105 405 -
Cash and cash equivalents at the end of the period
207 900 1,105 -
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

something is missing$3,963K Net proceeds fromthe loan$623K Net cash provided byfinancing activities$710K Canceled cashflow$3,876K Net decrease in cashand cash...-$693K Canceled cashflow$710K Common stock-basedcompensation and expenses,...$1,009K Accounts payable$241K Depreciation andamortization$58K Other items$20K Claims and advances-$10K Operating lease asset-$2K Net proceeds fromthe issuance of...-$3,876K Net cash used inoperating activities-$1,223K Canceled cashflow$1,340K Net cash used ininvesting activities-$170K Effects of exchange ratechanges on cash and cash...-$10K Net loss-$2,402K Accrued and otherliabilities-$98K Deposits and advances$37K Accounts receivable, net$24K Operating lease liability-$2K Acquisition and developmentof intangible...$169K Purchase of property,plant, and equipment$1K

IGC Pharma, Inc. (IGC)

IGC Pharma, Inc. (IGC)